SCHEMBL31661340

SCHEMBL31661340

O=c1cc(Cl)[nH]cc1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
GPR35 Q9HC97 2/20 0.41
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
TSHR P16473 4/20 0.39
CYP3A4 P08684 3/20 0.39
HPGD P15428 2/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPT P10636 1/20 0.39
GRIK1 P39086 1/20 0.39
GRIA1 P42261 1/20 0.39
GRIA2 P42262 1/20 0.39
GRIA3 P42263 1/20 0.39
GRIA4 P48058 1/20 0.39
BLM P54132 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1516544 0.72 TSHR (0.47) KDM4EGPR35CA12CA9TSHR
SCHEMBL9124172 0.68 GPR35 (0.45) KDM4EGPR35TSHRCYP3A4HPGD
SCHEMBL458846 0.68 KDM4E (0.61) KDM4EGPR35CA12CA9TSHR
SCHEMBL3975806 0.68 KDM4E (0.39) KDM4EGPR35TSHRCYP3A4HPGD
SCHEMBL29783588 0.68 TSHR (0.56) GPR35TSHRCYP3A4HPGDMAPK1
SCHEMBL3240210 0.68 TSHR (0.56) GPR35TSHRCYP3A4HPGDMAPK1
SCHEMBL16070109 0.67 KDM4E (0.39) KDM4EGPR35CA12CA9TSHR
SCHEMBL4708063 0.67 KDM4E (0.38) KDM4EGPR35TSHRCYP3A4HPGD
SCHEMBL4708066 0.67 KDM4E (0.38) KDM4EGPR35TSHRCYP3A4HPGD
SCHEMBL5250855 0.65 ALDH1A1 (0.44) KDM4EGPR35TSHRCYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151517-A1 THIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS ASSOCIATED WITH MISSFOLDING OF ALPHA-SYNUCLEIN PROTEIN WAVEBREAK THERAPEUTICS LIMITED (US) 2025-07-17 WO disclosed